Research Article
Chinese Patent Medicine as Adjuvant for Mild-to-Moderate Active Ulcerative Colitis: A Network Meta-Analysis of Randomized Controlled Trials
Figure 4
Rank probability for the adverse events, recurrence rate, disappearance of mucopurulent bloody stool/abdominal pain/diarrhea/tenesmus, and Mayo score.